05:37 PM EST, 02/20/2025 (MT Newswires) -- Evolent Health ( EVH ) reported a Q4 adjusted loss late Thursday of $0.02 per share, compared with earnings of $0.13 a year earlier.

Analysts polled by FactSet expected earnings of $0.03.

Revenue in the three months ended Dec. 31 rose to $646.5 million from $556.1 million a year earlier.

Analysts surveyed by FactSet expected $651.3 million.

The company expects revenue of $440 million to $470 million in Q1 and $2.06 billion to $2.11 billion in the full year.

Analysts polled by FactSet expect sales of $595.2 million in Q1 and $2.4 billion in the full year.

Shares of the company fell 2.9% in after-hours trading.